PDF(Pubmed)
Abstract：
The aim of the ITI Consensus Workshop on zygomatic implants was to provide Consensus Statements and Clinical Recommendations for the use of zygomatic implants.
Three systematic reviews and one narrative review were written to address focused questions on (1) the indications for the use of zygomatic implants; (2) the survival rates and complications associated with surgery in zygomatic implant placement; (3) long-term survival rates of zygomatic implants and (4) the biomechanical principles involved when zygoma implants are placed under functional loads. Based on the reviews, three working groups then developed Consensus Statements and Clinical Recommendations. These were discussed in a plenary and finalized in Delphi rounds.
A total of 21 Consensus Statements were developed from the systematic reviews. Additionally, the group developed 17 Clinical Recommendations based on the Consensus Statements and the combined expertise of the participants.
Zygomatic implants are mainly indicated in cases with maxillary bone atrophy or deficiency. Long-term mean zygomatic implant survival was 96.2% [95% CI 93.8; 97.7] over a mean follow-up of 75.4 months (6.3 years) with a follow-up range of 36-141.6 months (3-11.8 years). Immediate loading showed a statistically significant increase in survival over delayed loading. Sinusitis presented with a total prevalence of 14.2% [95% CI 8.8; 22.0] over a mean 65.4 months follow-up, representing the most common complication which may lead to zygomatic implant loss. The international experts suggested clinical recommendations regarding planning, surgery, restoration, outcomes, and the patient\'s perspective.
Three systematic reviews and one narrative review were written to address focused questions on (1) the indications for the use of zygomatic implants; (2) the survival rates and complications associated with surgery in zygomatic implant placement; (3) long-term survival rates of zygomatic implants and (4) the biomechanical principles involved when zygoma implants are placed under functional loads. Based on the reviews, three working groups then developed Consensus Statements and Clinical Recommendations. These were discussed in a plenary and finalized in Delphi rounds.
A total of 21 Consensus Statements were developed from the systematic reviews. Additionally, the group developed 17 Clinical Recommendations based on the Consensus Statements and the combined expertise of the participants.
Zygomatic implants are mainly indicated in cases with maxillary bone atrophy or deficiency. Long-term mean zygomatic implant survival was 96.2% [95% CI 93.8; 97.7] over a mean follow-up of 75.4 months (6.3 years) with a follow-up range of 36-141.6 months (3-11.8 years). Immediate loading showed a statistically significant increase in survival over delayed loading. Sinusitis presented with a total prevalence of 14.2% [95% CI 8.8; 22.0] over a mean 65.4 months follow-up, representing the most common complication which may lead to zygomatic implant loss. The international experts suggested clinical recommendations regarding planning, surgery, restoration, outcomes, and the patient\'s perspective.
摘要：
目的：ITI关于骨种植体的共识研讨会的目的是为骨种植体的使用提供共识声明和临床建议。
方法：撰写了三篇系统综述和一篇叙述性综述，以解决以下问题：（1）使用the骨植入物的适应症；（2）与the骨植入物放置手术相关的生存率和并发症；（3）the骨植入物的长期生存率；（4）在功能负荷下放置the骨植入物时涉及的生物力学原理。根据评论，随后,三个工作组制定了共识声明和临床建议.这些在全体会议上进行了讨论，并在Delphi回合中最终确定。
结果：从系统评价中得出总共21份共识声明。此外,该小组根据共识声明和参与者的专业知识制定了17项临床建议.
结论：上颌骨骨萎缩或缺损的病例主要适用于颌骨种植体。平均随访75.4个月（6.3年），随访范围为36-141.6个月（3-11.8年），长期平均zy骨植入物生存率为96.2％[95％CI93.8;97.7]。即时负荷显示与延迟负荷相比，存活率有统计学上的显着增加。在平均65.4个月的随访中，鼻窦炎的总患病率为14.2%[95%CI8.8;22.0]。这是最常见的并发症，可能导致颧骨种植体丢失。国际专家建议有关规划的临床建议，手术,restoration,结果，和病人的观点。
方法：撰写了三篇系统综述和一篇叙述性综述，以解决以下问题：（1）使用the骨植入物的适应症；（2）与the骨植入物放置手术相关的生存率和并发症；（3）the骨植入物的长期生存率；（4）在功能负荷下放置the骨植入物时涉及的生物力学原理。根据评论，随后,三个工作组制定了共识声明和临床建议.这些在全体会议上进行了讨论，并在Delphi回合中最终确定。
结果：从系统评价中得出总共21份共识声明。此外,该小组根据共识声明和参与者的专业知识制定了17项临床建议.
结论：上颌骨骨萎缩或缺损的病例主要适用于颌骨种植体。平均随访75.4个月（6.3年），随访范围为36-141.6个月（3-11.8年），长期平均zy骨植入物生存率为96.2％[95％CI93.8;97.7]。即时负荷显示与延迟负荷相比，存活率有统计学上的显着增加。在平均65.4个月的随访中，鼻窦炎的总患病率为14.2%[95%CI8.8;22.0]。这是最常见的并发症，可能导致颧骨种植体丢失。国际专家建议有关规划的临床建议，手术,restoration,结果，和病人的观点。
